Oslo, Norway, 30 April 2020: Photocure ASA (Photocure, PHO: OSE) will announce
the first quarter 2020 financial results on Thursday 7 May 2020 at 07:00 CET and
invites investors, analysts and the media to a presentation at 15:00 CET the
same day.
The investor presentation will be streamed live and be hosted by Daniel
Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and
questions can be submitted throughout the event.
The quarterly report and presentation will be published at 07:00 CET and will be
publicly available at www.photocure.com. The streaming event is available
through https://channel.royalcast.com/webcast/hegnarmedia/20200507_6/
The presentation is scheduled to conclude at 15:45 CET.
Please note that preliminary financial results for the first quarter of 2020
were announced in the trading update of 27 April 2020. The trading update is
available in the presentation of the agreement to regain the worldwide rights
for Hexvix: https://newsweb.oslobors.no/message/503877
For further information, please contact:
Photocure
Erik Dahl
CFO
Tel: +47 45055000
Email: ed@photocure.com
Media and IR enquiries:
Geir Bjørlo
Corporate Communications (Norway) Tel: +47 91540000
Email: geir.bjorlo@corpcom.no
About Photocure
Photocure: The Bladder Cancer Company delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, making
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com, www.hexvix.com, www.cysview.com
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.